Nature Biotechnology, Published online: 03 August 2026; doi:10.1038/s41587-026-03249-3 Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Excelsior Sciences is developing a closed-loop system for drug discovery using carbon building bloccs. Source: Read the original article on www.nature.com
Nature Biotechnology, Published online: 03 August 2026; doi:10.1038/s41587-026-03249-3
Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Excelsior Sciences is developing a closed-loop system for drug discovery using carbon building bloccs.